Skip to Main Content

Paper Details

A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity.
Ann Neurol
31
2015
G, H(+), IFN, MS, Na(+), RNA data sets, SLC9A9, SLC9A9 mRNA, SLC9a9, T cells, containin, interferon, intronic variant, multiple sclerosis, patients, primary T cells, rs9828519, target gene
Author NameAffiliation
Federica EspositoSan Raffaele Scientific Institute
Federica EspositoInstitute of Experimental Neurology, San Raffaele Scientific Institute
Elaine T LimAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital
Elaine T LimHarvard Medical School
Thomas PertelAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital
Thomas PertelHarvard Medical School
Vittorio MartinelliSan Raffaele Scientific Institute
Vittorio MartinelliInstitute of Experimental Neurology, San Raffaele Scientific Institute
Mariaemma RodegherSan Raffaele Scientific Institute
Mariaemma RodegherInstitute of Experimental Neurology, San Raffaele Scientific Institute
Howard L WeinerAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital
Howard L WeinerHarvard Medical School
David BrassatPurpan Hospital and Mixed Unit of Research 3, University of Toulouse
Nikolaos A PatsopoulosAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital
Nikolaos A PatsopoulosInstitute for the Neurosciences, Brigham and Women's Hospital
Nikolaos A PatsopoulosBroad Institute
Nikolaos A PatsopoulosHarvard Medical School
Giancarlo ComiSan Raffaele Scientific Institute
Giancarlo ComiInstitute of Experimental Neurology, San Raffaele Scientific Institute
Filippo Martinelli BoneschiSan Raffaele Scientific Institute
Filippo Martinelli BoneschiInstitute of Experimental Neurology, San Raffaele Scientific Institute
Philip L De JagerAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital
Philip L De JagerHarvard Medical School
Philip L De JagerBroad Institute
Philip L De JagerInstitute for the Neurosciences, Brigham and Women's Hospital
Philip L De JagerAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital
Philip L De JagerHarvard Medical School
Philip L De JagerBroad Institute
Philip L De JagerInstitute for the Neurosciences, Brigham and Women's Hospital
  • 1 - 29

Datasets